Optimization of β-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique

Journal of Nanoparticle Research

Volumn 11, Issue 3, 2009, Pages 601-614

  Triplett II, Michael D ^a   Rathman, James F ^b  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b The Ohio State University   (United States)

Author keywords

Carotene; Bile salts; High shear homogenization; Lipids; Lipophile and poorly soluble drug delivery; Solid lipid nanoparticle; Statistical methodology

Indexed keywords

BILE SALTS; HIGH SHEAR HOMOGENIZATION; LIPOPHILE AND POORLY-SOLUBLE DRUG DELIVERY; SOLID LIPID NANOPARTICLE; STATISTICAL METHODOLOGY;

ACIDS; BODY FLUIDS; DESIGN; DRUG DELIVERY; HOMOGENIZATION METHOD; OPTIMIZATION; PHOSPHOLIPIDS; POLYDISPERSITY; SALTS; STEARIC ACID;

NANOPARTICLES;

BETA CAROTENE; BILE SALT; SOLID LIPID NANOPARTICLE; STEARIC ACID; TAUROCHOLIC ACID;

ARTICLE; LIPOPHILICITY; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SHEAR STRENGTH; SURFACE PROPERTY;

EID: 61449207345     PISSN: 13880764     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11051-008-9402-3     Document Type: Article

References (16)

1. P Ahlin J Kristl J Smid-Korbar 1998 Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions Acta Pharm 48 259 267
2. C Bocca O Caputo R Cavalli 1998 Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles Int J Pharm 175 185 193
3. Domb AJ (1993) Lipospheres for controlled delivery of substances. United States Patent 5,188,837, 23 February 1993
4. I Fängmark JC Carpin 1996 Protein nebulization J Aerosol Sci 27 S231 S232
5. AJ Fillery-Travis LH Foster MM Robins 1995 Stability of emulsions stabilised by two physiological surfactants: l-α-phosphatidylcholine and sodium taurocholate Biophys Chem 54 253 260
6. A Fundarò R Cavalli A Bargoni 2000 Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats Pharmacol Res 42 337 343
7. Gregoriadis G, McCormack B (eds) (1998) Targeting of drugs 6: strategies for stealth therapeutic systems. Plenum Press, New York
8. Kumpulainen JT, Salonen JT (eds) (1996) Natural antioxidants and food quality in atherosclerosis and cancer prevention. Royal Society of Chemistry, Cambridge
9. Mann JJ (1980) Antifungal agents. In: Postgraduate course in internal medicine; v. 6, prog. 1, no. 2. Johns Hopkins University, Baltimore
10. W Mehnert K Mäder 2001 Solid lipid nanoparticles: production, characterization and applications Adv Drug Deliv Rev 47 165 196
11. RH Müller K Mäder S Gohla 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur J Pharm Biopharm 50 161 177
12. Powell MF, Newman MJ (eds) (1995) Vaccine design: the subunit and adjuvant approach. Plenum Press, New York
13. K Sato N Garti 1988
14. Schreier H (ed) (2001) Drug targeting technology: physical, chemical, biological methods. Marcel Dekker, New York
15. B Siekmann K Westesen 1994 Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles Colloids Surf B Biointerfaces 3 159 175
16. K Westesen B Siekmann 1997 Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles Int J Pharm 151 35 45